美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
59651-157-04	59651-157	HUMAN PRESCRIPTION DRUG	Dapagliflozin and Metformin hydrochloride	Dapagliflozin and Metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211489	Aurobindo Pharma Limited	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	10 mg/1; 1000 mg/1	400 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-157-04)
59651-157-30	59651-157	HUMAN PRESCRIPTION DRUG	Dapagliflozin and Metformin hydrochloride	Dapagliflozin and Metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211489	Aurobindo Pharma Limited	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	10 mg/1; 1000 mg/1	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-157-30)
59651-154-05	59651-154	HUMAN PRESCRIPTION DRUG	Dapagliflozin and Metformin hydrochloride	Dapagliflozin and Metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211489	Aurobindo Pharma Limited	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5 mg/1; 500 mg/1	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-154-05)
59651-154-30	59651-154	HUMAN PRESCRIPTION DRUG	Dapagliflozin and Metformin hydrochloride	Dapagliflozin and Metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211489	Aurobindo Pharma Limited	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5 mg/1; 500 mg/1	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-154-30)
59651-156-05	59651-156	HUMAN PRESCRIPTION DRUG	Dapagliflozin and Metformin hydrochloride	Dapagliflozin and Metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211489	Aurobindo Pharma Limited	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	10 mg/1; 500 mg/1	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-156-05)
59651-156-30	59651-156	HUMAN PRESCRIPTION DRUG	Dapagliflozin and Metformin hydrochloride	Dapagliflozin and Metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211489	Aurobindo Pharma Limited	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	10 mg/1; 500 mg/1	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-156-30)
59651-155-04	59651-155	HUMAN PRESCRIPTION DRUG	Dapagliflozin and Metformin hydrochloride	Dapagliflozin and Metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211489	Aurobindo Pharma Limited	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5 mg/1; 1000 mg/1	400 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-155-04)
59651-155-30	59651-155	HUMAN PRESCRIPTION DRUG	Dapagliflozin and Metformin hydrochloride	Dapagliflozin and Metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211489	Aurobindo Pharma Limited	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5 mg/1; 1000 mg/1	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-155-30)
59651-155-60	59651-155	HUMAN PRESCRIPTION DRUG	Dapagliflozin and Metformin hydrochloride	Dapagliflozin and Metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211489	Aurobindo Pharma Limited	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5 mg/1; 1000 mg/1	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-155-60)